Q2 2026 Holdings
Filed 2026-08-13 | 7 holdings | $881.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $326.5M | 2,847,541 | 37.1% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $151.0M | 6,800,099 | 17.1% |
| Sionna Therapeutics, Inc.(SION) | Common Stock | 829401108 | $131.8M | 2,995,602 | 15.0% |
| Kailera Therapeutics, Inc.(KLRA) | Common Stock | 482931102 | $113.9M | 5,171,282 | 12.9% |
| Disc Medicine, Inc.(IRON) | Common Stock | 254604101 | $110.7M | 1,513,875 | 12.6% |
| Q32 Bio, Inc.(QTTB) | Common Stock | 746964105 | $34.6M | 2,717,106 | 3.9% |
| Korro Bio, Inc.(KRRO) | Common Stock | 500946108 | $12.7M | 962,884 | 1.4% |